These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11598417)

  • 1. Enhanced relaxation to the rho-kinase inhibitor Y-27632 in mesenteric arteries from mineralocorticoid hypertensive rats.
    Weber DS; Webb RC
    Pharmacology; 2001; 63(3):129-33. PubMed ID: 11598417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of inhibitory effects of Y-27632, a Rho kinase inhibitor, in strips of small and large mesenteric arteries from spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Asano M; Nomura Y
    Hypertens Res; 2003 Jan; 26(1):97-106. PubMed ID: 12661918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide-treated rats.
    Büyükafşar K; Arikan O; Ark M; Kubat H; Ozveren E
    Eur J Pharmacol; 2004 Sep; 498(1-3):211-7. PubMed ID: 15363997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
    Banes AK; Watts SW
    Hypertension; 2001 Oct; 38(4):891-5. PubMed ID: 11641304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats.
    Watts SW; Gilbert L; Webb RC
    Hypertension; 1995 Dec; 26(6 Pt 2):1056-9. PubMed ID: 7498967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo.
    Chrissobolis S; Budzyn K; Marley PD; Sobey CG
    Stroke; 2004 Sep; 35(9):2200-5. PubMed ID: 15256679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
    Kansui Y; Fujii K; Goto K; Oniki H; Iida M
    Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):673-8. PubMed ID: 16895538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C.
    Chrissobolis S; Sobey CG
    Circ Res; 2001 Apr; 88(8):774-9. PubMed ID: 11325868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C.
    Barman SA
    Am J Physiol Lung Cell Mol Physiol; 2007 Aug; 293(2):L472-9. PubMed ID: 17468135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho-dependent kinase is involved in agonist-activated calcium entry in rat arteries.
    Ghisdal P; Vandenberg G; Morel N
    J Physiol; 2003 Sep; 551(Pt 3):855-67. PubMed ID: 12853654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of endothelin-1-induced potentiation of noradrenaline response in rat mesenteric artery.
    Matsumura Y; Kita S; Okui T
    Clin Exp Pharmacol Physiol; 2001 Jul; 28(7):540-4. PubMed ID: 11422221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension.
    Wehrwein EA; Northcott CA; Loberg RD; Watts SW
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1011-9. PubMed ID: 14982964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats.
    Nagaoka T; Morio Y; Casanova N; Bauer N; Gebb S; McMurtry I; Oka M
    Am J Physiol Lung Cell Mol Physiol; 2004 Oct; 287(4):L665-72. PubMed ID: 12959926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
    Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
    Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
    Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-induced contraction in mesenteric resistance arteries: signaling and changes in deoxycorticosterone acetate-salt hypertension.
    Watts SW
    Hypertension; 2002 Mar; 39(3):825-9. PubMed ID: 11897772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased RhoA/Rho-kinase signaling mediates spontaneous tone in aorta from angiotensin II-induced hypertensive rats.
    Jin L; Ying Z; Hilgers RH; Yin J; Zhao X; Imig JD; Webb RC
    J Pharmacol Exp Ther; 2006 Jul; 318(1):288-95. PubMed ID: 16569756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
    Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
    Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Rho-kinase and Src protein tyrosine kinase inhibition on agonist-induced vasoconstriction of arteries and veins of the equine laminar dermis.
    Robertson TP; Moore JN; Noschka E; Lewis TH; Lewis SJ; Peroni JF
    Am J Vet Res; 2007 Aug; 68(8):886-94. PubMed ID: 17669029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-kinase expression and its contribution to the control of perfusion pressure in the isolated rat mesenteric vascular bed.
    Büyükafşar K; Arikan O; Ark M; Seçilmiş A; Un I; Singirik E
    Eur J Pharmacol; 2004 Feb; 485(1-3):263-8. PubMed ID: 14757149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.